Hypoglycaemia with glucose levels below 3.0 mmol/l (54 mg/dl) occurs much more often than previously appreciated [46, 101]
Small changes, shifting by a few hours, or moving to a different day, can make a meaningful difference
Ro can prescribe medications like Ozempic and Wegovy, and it also offers compounded versions of GLP-1s if the branded versions are in shortage
The post points to documented insulin resistance, polycystic ovary syndrome, or impaired fasting glucose as the phenotypes where an insulin-sensitizing adjunct has a plausible rationale, identified using baseline insulin, HOMA-IR scores, and fasting glucose
In 2022, the company that owns the patent of Eriomin funded a small clinical trial involving 45 people, concluding that those who took it over a 12-week period had lower blood glucose and higher GLP-1 than those who took a placebo
[DOI] [PubMed] [Google Scholar] 80.Heymsfield SB, Coleman LA, Miller R, et al